Physiological characterisation of human iPS-derived dopaminergic neurons

Physiological characterisation of human iPS-derived dopaminergic neurons

Show other versions (1)

Human induced pluripotent stem cells (hiPSCs) offer the potential to study otherwise inaccessible cell types. Critical to this is the directed differentiation of hiPSCs into functional cell lineages. This is of particular relevance to research into neurological disease, such as Parkinson's dise...

Full description

Bibliographic Details
Main Authors:	Hartfield, E, Yamasaki-Mann, M, Ribeiro Fernandes, H, Vowles, J, James, W, Cowley, S, Wade-Martins, R
Format:	Journal article
Language:	English
Published:	Public Library of Science 2014

Similar Items

Physiological characterisation of human iPS-derived dopaminergic neurons
by: Hartfield, E, et al.
Published: (2014)

Impairment of mitochondrial calcium buffering links mutations in C9orf72 and TARDBP in iPS-derived motor neurons from patients with ALS/FTD
by: Dafinca, R, et al.
Published: (2020)

Cellular reprogramming: a new approach to modelling Parkinson's disease.
by: Hartfield, E, et al.
Published: (2012)

Elucidating the role of GBA in the pathology of Parkinson's disease using patient derived dopaminergic neurons differentiated from induced pluripotent stem cells.
by: Ribeiro Fernandes, HJ
Published: (2014)

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
by: Beevers, J, et al.
Published: (2013)

A functional characterisation of retrorubral field dopaminergic neurons
by: Bryden, LA
Published: (2021)

Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism
by: Okarmus, J, et al.
Published: (2021)

MAPT genetic variation and neuronal maturity alter isoform expression affecting axonal transport in iPSC-derived dopamine neurons.
by: Beevers, J, et al.
Published: (2017)

Studying α-Synuclein pathology using iPSC-derived dopaminergic neurons
by: Zambon, F
Published: (2017)

Modelling and analysis of LRRK2 mutations in iPSC-derived dopaminergic neurons and astrocytes
by: Booth, H
Published: (2017)

Transgene Excision Has No Impact on In Vivo Integration of Human iPS Derived Neural Precursors
by: Major, Tamara, et al.
Published: (2012)

Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons
by: Osaki, Tatsuya, et al.
Published: (2018)

ER stress and autophagic perturbations lead to elevated extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons
by: Fernandes, H, et al.
Published: (2016)

Immortalized striatal precursor neurons from Huntington’s disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics
by: Akimov, Sergey S, et al.
Published: (2021)

Representation of spontaneous movement by dopaminergic neurons is cell-type selective and disrupted in parkinsonism
by: Dodson, P, et al.
Published: (2016)

Human iPS-derived pre-epicardial cells direct cardiomyocyte aggregation expansion and organization in vitro
by: Tan, Jun Jie, et al.
Published: (2021)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons
by: Zambon, F, et al.
Published: (2019)

Identification of small molecules for human hepatocyte expansion and iPS differentiation
by: Shan, Jing, et al.
Published: (2014)

An improved technique for chromosomal analysis of human ES and iPS cells.
by: Moralli, D, et al.
Published: (2011)

An Improved Technique for Chromosomal Analysis of Human ES and iPS Cells
by: Moralli, D, et al.
Published: (2011)

CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells.
by: Flynn, R, et al.
Published: (2015)

Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells
by: Mungenast, Alison, et al.
Published: (2017)

Genetic engineering of human ES and iPS cells using TALE nucleases
by: Hockemeyer, Dirk, et al.
Published: (2012)

Modelling Mitchell-Riley Syndrome in vitro using iPS cells derived from RFX6 mutant patient
by: Alpagu, Yunus
Published: (2018)

Variant‐specific effects of GBA1 mutations on dopaminergic neuron proteostasis
by: Onal, G, et al.
Published: (2024)

Targeting TFEB and TFE3 in iPSC-derived dopaminergic neurons to correct autophagic/lysosomal deficits in Parkinson's disease
by: McGuinness, W
Published: (2023)

Human iPS derived progenitors bioengineered into liver organoids using an inverted colloidal crystal poly (ethylene glycol) scaffold
by: Blackford, Samuel J. I., et al.
Published: (2018)

Human iPS derived progenitors bioengineered into liver organoids using an inverted colloidal crystal poly (ethylene glycol) scaffold
by: Segal, Joe M., et al.
Published: (2019)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
by: Bengoa-Vergniory, N, et al.
Published: (2020)

Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.
by: Janezic, S, et al.
Published: (2013)

Genetic screening for molecules involved in dopaminergic neuron specification.
by: Koh, Venessa Sock-Kheng.
Published: (2013)

Optogenetic stimulation of a subset of dopaminergic neurons in drosophila
by: Chong, Melissa Hui Yan
Published: (2017)

Functional analysis of CX3CR1 in human induced pluripotent stem (iPS) cell‐derived microglia‐like cells
by: Murai, Nobuhito, et al.
Published: (2021)

Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons
by: Überbacher, C, et al.
Published: (2019)

Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson's disease.
by: Sandor, C, et al.
Published: (2017)

Molecular pathways governing development of vascular endothelial cells from ES/iPS cells
by: Tan, Keai Sinn, et al.
Published: (2013)

Engineering a perfusable 3D human liver platform from iPS cells
Published: (2021)

Engineering a perfusable 3D human liver platform from iPS cells
by: Schepers, Arnout, et al.
Published: (2022)

iPS-cell technology and the problem of genetic instability—can it ever be safe for clinical use?
by: Attwood, SW, et al.
Published: (2019)

Loss of microRNA-7 regulation leads to α-synuclein accumulation and dopaminergic neuronal loss in vivo
by: McMillan, K, et al.
Published: (2017)